Dr. Mukesh Kumar Yadav is working as Professor at the Department of Microbiology, Central University of Punjab, Bathinda, India. Prof. Yadav has more than 15 years of research experience in medical microbiology, particularly in microbial biofilms and host-microbial interactions. Prof. Yadav has published over 110 research articles, garnering more than 7,000 citations, and has authored five books with Elsevier. He has completed eight major research projects funded by the Indian Council of Medical Research (ICMR), the Department of Biotechnology (DBT), the Department of Science and Technology (DST), and the National Research Foundation (South Korea). Prof. Yadav's research area focuses on host-microbial interactions and microbial biofilms, including pathogenic and commensal bacteria in the gut. Prof. Yadav's lab is working on understanding microbial biofilms and infections caused by the biofilm mode of growth, as well as antimicrobial resistance (AMR), and identifying suitable strategies to combat AMR and drug resistance. Understanding Commensal Bacterial Interaction and Dysbiosis of Gut Microbiota during Various Metabolic Disorders.Dr. Balachandar Vellingiri currently is investigating various neurological diseases and developing human induced pluripotent stem cells (HiPSCs). Exploring the cutting-edge molecular, cellular, and translational neuroscience approaches, he aims to unravel disease mechanisms, identify therapeutic targets, and develop innovative interventions to slow or reverse neurological diseases. His expertise is on several techniques such as molecular cytogenetics, pathway analysis, and techniques in developing HiPSCs and Brain organoids, especially for neurological diseases.

• 1. Overview of Neurodegenerative Disorders2. Gut Microbiota and Neurological Diseases3. Gut-Brain Axis4. Gut-Brain Axis in Neurological Diseases5. Difference in the constitution of Gut Microbiota during Neurodegenerative Disorders6. Gut Metabolites in Neurodegenerative Diseases7. Influence of Gut Microbiota on Cerebellum8. Influence of Gut Microbiota on Hippocampus9. Influence of Gut Microbiota on Axonal Cells of the brain10. Mechanistic action of Gut Microbiota on Glial cells11. Gut as a second brain- Largest producer of serotonin12. Gradual Shift of gut microbial Population as a diagnostic marker for Neurodegenerative disorders13. Gut metabolites – effective biomarker for Neurodegenerative disorder14. Protocol – Isolation of Gut Microbiome from Faecal sample15. Gut metabolites isolation from Blood16. Metagenomics and sequence analysis17. Computer aided detection method18. Existing therapeutic options to alter gut composition in Neurodegenerative Disorders19. Dietary and Gut microbiome20. Ongoing clinical trials21. Ethical hurdles for the treatment of a disease focusing Gut Microbiota22. Futuristic therapies in pipeline for the betterment of Neurodegenerative Disorders

Dr. Mukesh Kumar Yadav is working as Professor at the Department of Microbiology, Central University of Punjab, Bathinda, India. Prof. Yadav has more than 15 years of research experience in medical microbiology, particularly in microbial biofilms and host-microbial interactions. Prof. Yadav has published over 110 research articles, garnering more than 7,000 citations, and has authored five books with Elsevier. He has completed eight major research projects funded by the Indian Council of Medical Research (ICMR), the Department of Biotechnology (DBT), the Department of Science and Technology (DST), and the National Research Foundation (South Korea). Prof. Yadav's research area focuses on host-microbial interactions and microbial biofilms, including pathogenic and commensal bacteria in the gut. Prof. Yadav's lab is working on understanding microbial biofilms and infections caused by the biofilm mode of growth, as well as antimicrobial resistance (AMR), and identifying suitable strategies to combat AMR and drug resistance. Understanding Commensal Bacterial Interaction and Dysbiosis of Gut Microbiota during Various Metabolic Disorders.Dr. Balachandar Vellingiri currently is investigating various neurological diseases and developing human induced pluripotent stem cells (HiPSCs). Exploring the cutting-edge molecular, cellular, and translational neuroscience approaches, he aims to unravel disease mechanisms, identify therapeutic targets, and develop innovative interventions to slow or reverse neurological diseases. His expertise is on several techniques such as molecular cytogenetics, pathway analysis, and techniques in developing HiPSCs and Brain organoids, especially for neurological diseases.

• 1. Overview of Neurodegenerative Disorders2. Gut Microbiota and Neurological Diseases3. Gut-Brain Axis4. Gut-Brain Axis in Neurological Diseases5. Difference in the constitution of Gut Microbiota during Neurodegenerative Disorders6. Gut Metabolites in Neurodegenerative Diseases7. Influence of Gut Microbiota on Cerebellum8. Influence of Gut Microbiota on Hippocampus9. Influence of Gut Microbiota on Axonal Cells of the brain10. Mechanistic action of Gut Microbiota on Glial cells11. Gut as a second brain- Largest producer of serotonin12. Gradual Shift of gut microbial Population as a diagnostic marker for Neurodegenerative disorders13. Gut metabolites – effective biomarker for Neurodegenerative disorder14. Protocol – Isolation of Gut Microbiome from Faecal sample15. Gut metabolites isolation from Blood16. Metagenomics and sequence analysis17. Computer aided detection method18. Existing therapeutic options to alter gut composition in Neurodegenerative Disorders19. Dietary and Gut microbiome20. Ongoing clinical trials21. Ethical hurdles for the treatment of a disease focusing Gut Microbiota22. Futuristic therapies in pipeline for the betterment of Neurodegenerative Disorders

Dr. Mukesh Kumar Yadav is working as Professor at the Department of Microbiology, Central University of Punjab, Bathinda, India. Prof. Yadav has more than 15 years of research experience in medical microbiology, particularly in microbial biofilms and host-microbial interactions. Prof. Yadav has published over 110 research articles, garnering more than 7,000 citations, and has authored five books with Elsevier. He has completed eight major research projects funded by the Indian Council of Medical Research (ICMR), the Department of Biotechnology (DBT), the Department of Science and Technology (DST), and the National Research Foundation (South Korea). Prof. Yadav's research area focuses on host-microbial interactions and microbial biofilms, including pathogenic and commensal bacteria in the gut. Prof. Yadav's lab is working on understanding microbial biofilms and infections caused by the biofilm mode of growth, as well as antimicrobial resistance (AMR), and identifying suitable strategies to combat AMR and drug resistance. Understanding Commensal Bacterial Interaction and Dysbiosis of Gut Microbiota during Various Metabolic Disorders.Dr. Balachandar Vellingiri currently is investigating various neurological diseases and developing human induced pluripotent stem cells (HiPSCs). Exploring the cutting-edge molecular, cellular, and translational neuroscience approaches, he aims to unravel disease mechanisms, identify therapeutic targets, and develop innovative interventions to slow or reverse neurological diseases. His expertise is on several techniques such as molecular cytogenetics, pathway analysis, and techniques in developing HiPSCs and Brain organoids, especially for neurological diseases.

• 1. Overview of Neurodegenerative Disorders2. Gut Microbiota and Neurological Diseases3. Gut-Brain Axis4. Gut-Brain Axis in Neurological Diseases5. Difference in the constitution of Gut Microbiota during Neurodegenerative Disorders6. Gut Metabolites in Neurodegenerative Diseases7. Influence of Gut Microbiota on Cerebellum8. Influence of Gut Microbiota on Hippocampus9. Influence of Gut Microbiota on Axonal Cells of the brain10. Mechanistic action of Gut Microbiota on Glial cells11. Gut as a second brain- Largest producer of serotonin12. Gradual Shift of gut microbial Population as a diagnostic marker for Neurodegenerative disorders13. Gut metabolites – effective biomarker for Neurodegenerative disorder14. Protocol – Isolation of Gut Microbiome from Faecal sample15. Gut metabolites isolation from Blood16. Metagenomics and sequence analysis17. Computer aided detection method18. Existing therapeutic options to alter gut composition in Neurodegenerative Disorders19. Dietary and Gut microbiome20. Ongoing clinical trials21. Ethical hurdles for the treatment of a disease focusing Gut Microbiota22. Futuristic therapies in pipeline for the betterment of Neurodegenerative Disorders